Activity 1: The Role of Multi-gene Predictors in Early Breast Cancer

Release Date: July 5, 2010
Expiration Date: July 5, 2011

Media:

Video/slides; Printable PDF also available.

Target Audience

Healthcare professionals who focus on oncology as a therapeutic specialty: oncologists, breast cancer surgeons, radiologists, advanced health practitioners, nurses, nurse practitioners, and physician assistants.

Statement of Need

Breast cancer has become a primary focus of national quality assessment efforts because it is prevalent, effective treatments are available, and gaps in care exist.¹ Although significant advances in the prevention, diagnosis, and management of breast cancer have been made in recent years, these scientific discoveries are not being translated effectively into clinical practice. More consistent application of evidence-based medicine and timely integration of scientific advances could improve the outcomes of thousands of lives. This television studio-based activity will use a town hall format to showcase breast cancer experts and an academic audience to discuss, debate, and challenge trial results and approaches on the use of diagnostic and prognostic molecular profiling.

¹ Hassett MJ, et al. Selecting high priority quality measures for breast cancer quality improvement. Med Care. 2008; 46(8):762-70.

Learning Objective

At the conclusion of this presentation, the participant will be able to:

• Evaluate the results of recent studies on molecular profiling of breast cancer and apply the knowledge gained to determine the most appropriate treatment strategies for patients.

Faculty Information and Disclosures

	William J. Gradishar, MD, FACP (Chair) Professor of Medicine Director of Breast Oncology Program Director Hematology/Oncology Fellowship Training Program Robert H. Lurie Comprehensive Cancer Center Northwestern University Feinberg School of Medicine Chicago, Illinois Dr. Gradishar has no relevant financial relationships to disclose relating to the content of this activity.
	D. Craig Allred, MD Professor Department of Pathology and Immunology Washington University School of Medicine St. Louis, Missouri Dr. Allred has disclosed that he serves on a medical advisory board for Clarient, Inc.
	Terry Mamounas, MD, MPH, FACS Professor of Surgery Northeastern Ohio Universities College of Medicine Medical Director, Aultman Cancer Center Canton, Ohio Dr. Mamounas has disclosed that he serves on a speakers’ bureau for Genomic Health, Inc.

The planners and managers have no financial or other relationship to products or devices with commercial interests related to the content of this CE/CME activity.

Instructions

To receive a statement of credit, you must:

• Review the full content of the activity and reflect upon its teachings
• Complete the pre-test and post-test questions. You will have three (3) opportunities to complete the post-test. Successful completion is 70% or higher.
• Complete the evaluation at the end of the activity.

Your statement of credit will be issued immediately upon successful completion of the post-test and evaluation form.

Accreditation

PHYSICIAN ACCREDITATION STATEMENT

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of The University of North Texas Health Science Center at Fort Worth Office of Professional and Continuing Education and Creative Educational Concepts, Inc. The University of North Texas Health Science Center at Fort Worth Office of Professional and Continuing Medical Education is accredited by the ACCME to provide continuing medical education for physicians.

The University of North Texas Health Science Center at Fort Worth Office of Professional and Continuing Education is accredited by the American Osteopathic Association to award continuing medical education to physicians.

PHYSICIAN CREDIT STATEMENT

The University of North Texas Health Science Center at Fort Worth designates this educational activity for a maximum of 1.5 AMA/PRA Category 1 Credits™.

The University of North Texas Health Science Center has requested that the AOA Council on Continuing Medical Education approve this program for 1.5 hours of AOA Category 2A CME credits. Approval is currently pending.

Physicians should only claim credit commensurate with the extent of their participation in the activity.

NURSING ACCREDITATION

The University of North Texas Health Science Center at Fort Worth Office of Professional and Continuing Medical Education is an approved provider of continuing nursing education by the Texas Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

This activity provides 1.5 contact hours for the nurse.

Fee

This activity is complimentary.

Disclosure Declaration

It is the policy of the University of North Texas Health Science Center at Fort Worth Office of Professional and Continuing Medical Education and CEC to ensure independence, balance, objectivity, scientific rigor, and integrity in their continuing education activities.

Those involved in the development of this continuing education activity have made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education activity. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, and precautions) and drug delivery systems is subject to change, however, and the reader is advised to check the manufacturer's package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.

Fair balance is achieved through ongoing and thorough review of all presentation materials produced by faculty, and all educational and advertising materials produced by supporting organizations, prior to educational offerings. Approval of credit for this continuing education activity does not imply endorsement by the University of North Texas Health Science Center  Office of Professional and Continuing Medical Education or CEC for any product or manufacturer identified.

Unlabeled Use Disclosure

This activity may include discussions of products or devices that are not currently approved for use by the Food and Drug Administration (FDA), or are currently investigational.

Supporting Organization

This activity is supported by educational grants from Genentech BioOncology and Pfizer.

This activity is co-provided by ONECONSORTIUM^TM members:  

Software Requirements

To view the activities on this website, your computer needs to have Internet Explorer 6.0 (or higher) or Mozilla Firefox 2 (or higher) or Safari 2 (or higher) and Adobe Flash Player 9.0 (or higher). If you are using a modem to connect to the Internet, you will need a modem speed of at least 56K to view the pages of the site. Video content requires DSL and higher. Adobe Flash Player is required to complete the self-assessment and Adobe Reader is required to print your certificate. You can download Adobe Reader for free. As you will be printing your CME/CE certificate online, your computer must be connected to a printer.